Revati Shreeniwas

Revati Shreeniwas

President på
Revati, Inc.
65 år
Health Technology
Consumer Services
Commercial Services

Profil

Currently, Revati Shreeniwas is President at Revati, Inc. since 2004 and a Member at Continuing Medical Education, Inc. Formerly, Dr. Shreeniwas was Chief Medical Officer at Bright Minds Biosciences, Inc. from 2020 to 2022, Chief Medical Officer at NeurAxon Pharma, Inc. from 2015 to 2017, Vice President-Clinical Development at Soleno Therapeutics, Inc. from 2019 to 2020, Vice President-Clinical Research & Development at Alvine Pharmaceuticals, Inc., Principal at Scios, Inc., Principal at CV Therapeutics, Inc., Principal at The Trustees of Columbia University in The City of New York, Professor at Stanford University.

Aktiva positioner av Revati Shreeniwas

FöretagPositionStart
Företagsledare/Principal -
Revati, Inc.
President 2004-01-01

Tidigare kända positioner av Revati Shreeniwas

FöretagPositionSlut
BRIGHT MINDS BIOSCIENCES INC. Teknisk/Vetenskaplig/F&U Direktör 2022-12-01
SOLENO THERAPEUTICS, INC. Teknisk/Vetenskaplig/F&U Direktör 2020-06-01
Teknisk/Vetenskaplig/F&U Direktör 2017-01-01
Företagsledare/Principal -
Företagsledare/Principal -
Se detaljerna i Revati Shreeniwass erfarenhet

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

4

Första gradens relationer

10

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag10

Health Technology

Health Technology

Revati, Inc.

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

  1. Börsen
  2. Insiders
  3. Revati Shreeniwas